KAR-2581

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameKAR-2581
Drug Alias NameK-2000 seriessystemic anti-inflammatory OS-HDIPan-HDAC Inhibitors (Karus)KAR-2581OS-HDI-3
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsRejection of organ transplantationPsoriasisLupus Erythematosus, Systemic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKarus Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKarus Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationPsoriasisLupus Erythematosus, Systemic +[6] 

Other Information

ATC CodeN/A
Related LinksN/A